Jason S Slakter Selected Research

Nausea

1/2017

Oral Tyrosine Kinase Inhibitor for Neovascular Age-Related Macular Degeneration: A Phase 1 Dose-Escalation Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason S Slakter Research Topics

Disease

33	Macular Degeneration (Age-Related Maculopathy) 10/2023 - 02/2002
22	Choroidal Neovascularization 01/2015 - 02/2002
6	Macular Edema 11/2016 - 03/2006
3	Geographic Atrophy 10/2023 - 01/2020
3	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2016 - 09/2006
3	Polypoidal Choroidal Vasculopathy 01/2015 - 10/2002
3	Central Serous Chorioretinopathy 07/2014 - 06/2003
3	Retinal Vein Occlusion 05/2011 - 03/2006
2	Endophthalmitis (Ophthalmia) 01/2020 - 10/2009
2	Hemorrhage 05/2011 - 02/2009
2	Inflammation (Inflammations) 11/2009 - 10/2009
2	Back Pain (Backache) 02/2004 - 10/2002
1	Vivax Malaria 01/2019
1	Neoplasms (Cancer) 09/2018
1	Hemangioblastoma 09/2018
1	Retinal Detachment (Retinal Detachments) 09/2018
1	Edema (Dropsy) 09/2018
1	Muscle Cramp (Cramp) 01/2017
1	Nausea 01/2017
1	Anorexia 01/2017
1	Fatigue 01/2017
1	Diarrhea 01/2017
1	Polyps 01/2015
1	Telangiectasis (Telangiectasia) 09/2006
1	Retinal Perforations 09/2006
1	Cicatrix (Scar) 09/2006
1	Contracture 09/2006
1	Choroidal Effusions 05/2005
1	Injection Site Reaction 02/2004
1	Myopia 04/2003
1	Pain (Aches) 02/2002

Drug/Important Bio-Agent (IBA)

12	Verteporfin (Visudyne)FDA Link 05/2012 - 02/2002
9	Fluorescein (Funduscein)FDA LinkGeneric 08/2013 - 02/2002
8	Ranibizumab (Lucentis)FDA Link 01/2015 - 09/2007
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 11/2009
6	Bevacizumab (Avastin)FDA Link 09/2018 - 03/2006
6	afliberceptIBA 11/2016 - 11/2009
6	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2015 - 06/2003
6	anecortave acetateIBA 09/2006 - 02/2003
5	Retinaldehyde (Retinal)IBA 09/2018 - 10/2002
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2012 - 04/2004
3	pegcetacoplanIBA 10/2023 - 01/2020
2	Angiogenesis InhibitorsIBA 12/2003 - 02/2003
1	salicylhydroxamic acid (SHAM)IBA 10/2023
1	PlacebosIBA 10/2023
1	Complement Inactivating AgentsIBA 01/2021
1	Complement C3 (C3 Complement)IBA 01/2020
1	tafenoquineIBA 01/2019
1	SteroidsIBA 09/2018
1	Alanine Transaminase (SGPT)IBA 01/2017
1	Transaminases (Aminotransferases)IBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2014
1	cadherin 5IBA 07/2014
1	Proteins (Proteins, Gene)FDA Link 11/2009
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2009
1	Immunoglobulin G (IgG)IBA 11/2009

Therapy/Procedure

13	Photochemotherapy (Photodynamic Therapy) 05/2012 - 02/2002
9	Therapeutics 12/2018 - 02/2002
5	Injections 10/2023 - 10/2009
5	Intravitreal Injections 09/2018 - 03/2006
5	Lasers (Laser) 09/2018 - 09/2006
3	Light Coagulation 11/2016 - 09/2006
3	Radiotherapy 01/2015 - 09/2013
2	Brachytherapy 08/2013 - 02/2013
1	Aftercare (After-Treatment) 09/2018
1	Drug Therapy (Chemotherapy) 09/2018
1	Retreatment 02/2013
1	Intraocular Injections 11/2009